Estonia vs Taiwan, China: Protecting minority investors: Ease of shareholder suits index (0-10)
Estonia
60
in 2013
Taiwan, China
60
in 2013
Estonia rank
78th
Taiwan, China rank
78th
Protecting minority investors: Ease of shareholder suits index (0-10) over time
- Estonia
- Taiwan, China
How they compare
Estonia currently reports 60 against 60 in Taiwan, China, a difference of 0.
The two have swapped places 1 time across 9 shared years of data; in 2005 it was Estonia ahead.
Estonia ranks 78th and Taiwan, China ranks 78th of 191 countries.
Estonia has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Estonia | Taiwan, China | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 60 | 50 | 10 | Estonia |
| 2010s | 60 | 52.5 | 7.5 | Estonia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher protecting minority investors: ease of shareholder suits index (0-10), Estonia or Taiwan, China?
- Estonia, at 60 against 60 in Taiwan, China as of 2013.
- What is the difference in protecting minority investors: ease of shareholder suits index (0-10) between Estonia and Taiwan, China?
- 0, with Estonia ahead.
- How many years of comparable data are there for Estonia and Taiwan, China?
- 9 years are reported by both, from 2005 to 2013.
- How do Estonia and Taiwan, China rank globally for protecting minority investors: ease of shareholder suits index (0-10)?
- Estonia ranks 78th and Taiwan, China ranks 78th of 191 countries.
- Where does this data come from?
- The World Bank, published as Protecting minority investors: Ease of shareholder suits index (0-10) (DB06-14 methodology) - Score. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The score for ease of shareholder suits index benchmarks economies with respect to the regulatory best practice on the indicator. The score is indicated on a scale from 0 to 100, where 0 represents the worst regulatory performance and 100 the best regulatory performance, and is computed based on the methodology in the DB06-14 studies.